202 related articles for article (PubMed ID: 2237046)
1. [Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment].
Keller U; Golay A; Pometta D
Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1199-204. PubMed ID: 2237046
[TBL] [Abstract][Full Text] [Related]
2. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
5. [Disorders of lipid metabolism in diabetes mellitus].
Biesenbach G
Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631
[TBL] [Abstract][Full Text] [Related]
6. [Dyslipidemia in diabetes mellitus].
Niemeijer-Kanters SD; Banga JD; Erkelens DW
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
[TBL] [Abstract][Full Text] [Related]
7. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
Udawat H; Goyal RK
Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic dyslipoproteinemia.
Steinmetz A
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):239-45. PubMed ID: 12951627
[TBL] [Abstract][Full Text] [Related]
9. [Lipid-lowering therapy in patients with type-2 diabetes mellitus].
Pados G; Audikovszky M
Orv Hetil; 2003 Mar; 144(12):557-61. PubMed ID: 12723526
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations.
Walden CE; Knopp RH; Wahl PW; Beach KW; Strandness E
N Engl J Med; 1984 Oct; 311(15):953-9. PubMed ID: 6472421
[TBL] [Abstract][Full Text] [Related]
12. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
Yoshida H; Hirowatari Y; Kurosawa H; Tada N
Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
[TBL] [Abstract][Full Text] [Related]
13. Lipids in type 2 diabetes.
Laakso M
Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
[TBL] [Abstract][Full Text] [Related]
14. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
McKenney JM
Pharmacotherapy; 1993; 13(4):340-52. PubMed ID: 8361860
[TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
17. Lipid and lipoprotein profiles in Ethiopian patients with diabetes mellitus.
Siraj ES; Seyoum B; Saenz C; Abdulkadir J
Metabolism; 2006 Jun; 55(6):706-10. PubMed ID: 16713427
[TBL] [Abstract][Full Text] [Related]
18. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
19. Diabetic dyslipidaemia.
Erkelens DW
Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
[TBL] [Abstract][Full Text] [Related]
20. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
Balogh Z; Seres I; Harangi M; Kovács P; Kakuk G; Paragh G
Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]